Desai Anuja, Kinkhabwala Ravish, Mehta Parin, Prajapati Bhavik
Department of Ophthalmology, Kusum Dhirajlal Hospital, Ahmedabad, Gujarat, India.
Clin Ophthalmol. 2025 Sep 18;19:3431-3437. doi: 10.2147/OPTH.S548323. eCollection 2025.
To report the initial refractive and visual outcomes of keratorefractive lenticule extraction (KLEx) procedures using the 2MHz femtosecond laser platform in myopia and myopic astigmatism.
All eyes meeting the following inclusion and exclusion criteria from April to June 2024 were selected for the study. The study included patients >18 years of age with vision 20/25 or better, myopia with SEQ of -0.5D to -12.5D, residual stromal thickness >300 microns and stable refraction for one year. Excluded were those with hypermetropia, mixed astigmatism, corneas <480 microns, corneal diseases, active illnesses, pregnancy, abnormal corneal shape, and patients not able to commit to a 3-month follow-up.
A total of 198 eyes (102 patients) comprising 45 (44.1%) females and 57 (55.9%) males, with a mean age of 23.9 ± 4.8 years, were considered for statistical analysis. 90.4% of the eyes achieved 20/20 UDVA or better after surgery. Correlation between attempted SEQ and achieved SEQ was 0.9636 implying high predictability. Our study demonstrated high accuracy with 100% eyes achieving SEQ ± 1.00D of intended target and 91.9% of eyes within 0.5D of intended target SEQ. The present study confirms the refractive stability with minimal changes (-0.04D relative to the intended target) over 3 months of follow up.
The present study shows that the KLEx procedure is highly efficacious and safe, with visual and refractive outcomes showing good predictability and stability.
报告使用2MHz飞秒激光平台进行角膜屈光透镜切除术(KLEx)治疗近视和近视散光的初始屈光和视觉效果。
选取2024年4月至6月所有符合以下纳入和排除标准的眼睛进行研究。该研究纳入年龄大于18岁、视力20/25或更好、等效球镜度(SEQ)为-0.5D至-12.5D的近视患者、剩余基质厚度大于300微米且屈光稳定一年的患者。排除远视、混合散光、角膜厚度小于480微米、角膜疾病、活动性疾病、妊娠、角膜形状异常以及无法承诺进行3个月随访的患者。
共有198只眼(102例患者)纳入统计分析,其中女性45只眼(44.1%),男性57只眼(55.9%),平均年龄23.9±4.8岁。90.4%的眼睛术后裸眼视力达到20/20或更好。预期SEQ与实际SEQ之间的相关性为0.9636,意味着预测性高。我们的研究显示准确性高,100%的眼睛达到预期目标SEQ±1.00D,91.9%的眼睛在预期目标SEQ的0.5D范围内。本研究证实了随访3个月期间屈光稳定性极佳,相对于预期目标仅有微小变化(-0.04D)。
本研究表明,KLEx手术高效且安全,视觉和屈光效果具有良好的可预测性和稳定性。